首页 | 本学科首页   官方微博 | 高级检索  
检索        

核因子-κB在三阴性乳腺癌中的表达及其意义
引用本文:罗湘,史艳侠,李志铭,孙月丽,姜文奇.核因子-κB在三阴性乳腺癌中的表达及其意义[J].临床肿瘤学杂志,2011,16(5):417-420.
作者姓名:罗湘  史艳侠  李志铭  孙月丽  姜文奇
作者单位:1 337000 萍乡市人民医院肿瘤科 2 510060 华南肿瘤学国家重点实验室 3 510060 中山大学肿瘤防治中心肿瘤内科
摘    要:目的 探讨核因子-κB(NF-κB)在三阴性乳腺癌组织中的表达及其与临床病理特征和预后的关系。方法 应用免疫组化法PV-6000二步法检测137例三阴性乳腺癌和132例非三阴性乳腺癌患者癌组织NF-κB的表达,分析其与临床病理特征和预后之间的关系。结果 137例三阴性乳腺癌组织中的NF-κB阳性表达率为73.7%(101/137),明显高于非三阴性乳腺癌的46.2%(61/132),差异有统计学意义(=0.000)。在137例三阴性乳腺癌中,NF-κB表达与VEGF、p53、组织分级、淋巴结转移、5年无病生存率和5年总生存率有关(<0.05);而在132例非三阴性乳腺癌中,NF-κB表达仅与VEGF、淋巴结转移、5年无病生存率相关(<0.05)。结论 NF-κB在三阴性乳腺癌中表达率高,并可作为三阴性乳腺癌的预后指标。

关 键 词:乳腺肿瘤  核因子-κB  临床病理特征  预后
收稿时间:2010-09-08
修稿时间:2011-02-20

The expression of nuclear factor kappa B in triple negative breast cancer and its clinical significance
LUO Xiang,SHI Yan-xia,LI Zhi-ming,SUN Yue-li,JIANG Wen-qi.The expression of nuclear factor kappa B in triple negative breast cancer and its clinical significance[J].Chinese Clinical Oncology,2011,16(5):417-420.
Authors:LUO Xiang  SHI Yan-xia  LI Zhi-ming  SUN Yue-li  JIANG Wen-qi
Institution:LUO Xiang,SHI Yan-xia,LI Zhi-ming,SUN Yue-li,JIANG Wen-qi.Department of Medical Oncology,Pingxiang People Hospital,Pingxiang 337000,China
Abstract:Objective To explore the expression of nuclear factor kappa B(NF-κB) and its relationship with clinicopathological parameters in triple-negative breast cancer(negative estrogen receptor,negative progesterone receptor and negative HER-2).Methods Immunohistochemical assays were performed to determine the expression of NF-κB in 137 cases of triple-negative breast cancer and 132 cases of non-triple negative breast cancer.The relationships between immunohistochemicaI results and clinicopathological data and prognosis were analyzed.Results The positive expression rate of NF-κB was 73.7%(101/137) in triple negative breast cancer,which was higher than 46.2%(61/132)in non-triple negative breast cancer,with statistical significance(P=0.000).It correlated to VEGF(P=0.024),p53(P=0.0486),tumor grade(P=0.028),node status(P=0.038),5-year disease free survival(P=0.014) and 5-year overall survival(P=0.008) in triple negative breast cancer,but only related to VEGF(P=0.038),node status(P=0.040) and 5-year disease free survival(P=0.021)in non-triple negative breast cancer.Conclusion The expression of NF-κB is high,and it is a significant prognostic factor in triple-negative breast cancer.
Keywords:Breast neoplasm  Nuclear factor kappa B  Clinicopathological characteristic  Prognosis  
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《临床肿瘤学杂志》浏览原始摘要信息
点击此处可从《临床肿瘤学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号